# 2025-15161: Chattem Chemicals Seeks Bulk Manufacturing License for Controlled Substances

2025-15161, Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-08-11 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-15161
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-15161
- Title: Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 38668
- Published: 2025-08-11
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Chattem Chemicals Seeks Bulk Manufacturing License for Controlled Substances

## Summary

Chattem Chemicals wants to get official approval to make large amounts of certain controlled substances. This affects anyone involved in drug manufacturing and regulation, as it could change who supplies these important chemicals. Keep an eye out for updates on approvals and any new rules that might come with this change.

## Abstract

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2025-15161 on federalregister.gov](https://www.federalregister.gov/documents/2025/08/11/2025-15161/bulk-manufacturer-of-controlled-substances-application-chattem-chemicals)
- [2025-15161 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-08-11/pdf/2025-15161.pdf)

## Related
- [Previous: 2025-15160, Importer of Controlled Substances Application: Experic LLC](https://policyrisk.com/federal-register/2025-15160)
- [Next: 2025-15162, Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Resea…](https://policyrisk.com/federal-register/2025-15162)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-15161 (as of 2026-06-08).
